Proton Therapy and Care Capital establish PTGM

Proton Therapy, a US healthcare technology company, and Care Capital, a developer and investor in primary healthcare property, have announced the formation of Proton Therapy Global Management (PTGM).

PTGM will design, develop and manage a global network of proton-therapy centres, providing cancer patients with access to the treatment.

The company will develop and manage proton-therapy facilities in partnership with some of the world’s most prominent hospitals.

To date, letters of intent have been signed to build five centres in the US and UK, including two at academic cancer-research centres and one at a site in central London.